On Monday, November 16, 2020, the Company, Onconova Therapeutics, Inc., ONTX stock construct a change of -2.34 percent (Loss) in a total of its share price and having its trading value $0.26, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $52.24M with the total Outstanding Shares of 183.58M.
P/S, P/E, P/B & P/C values of (NASDAQ: ONTX):
Onconova Therapeutics, Inc. institutional ownership is standing at 9.8 percent, while insider ownership is 0.2 percent. As of now, ONTX has a P/S, P/E and, P/B values of 261.22, 0, and 2.87 respectively. Its P/Cash is valued at 1.92.
The stock SMA50 is now at -4.94 percent. In looking, the SMA 200 we see that the stock has seen a -44.97 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Profitability ratios:
Looking into the profitability ratios of ONTX stock, an investor will find its ROE, ROA, ROI standing at -178.7 percent, -84.5 percent and, -187.1 percent, respectively.
Beta Factor:
A beta factor is used to measure the volatility of the stock. The stock remaining at 7.1 percent volatile for the week and 6.71 percent for the month.
Gross / Operating Margins of ONTX:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price:
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Onconova Therapeutics, Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of Onconova Therapeutics, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at -1.15 percent, resulting in a performance for the month at -10.96 percent.
Therefore, the stated figure displays a quarterly performance of -75.16 percent, bringing six-month performance to -28.49 percent and year to date performance of -32.56 percent. As of now, Onconova Therapeutics, Inc. has a P/S, P/E and, P/B values of 261.22, 0, and 2.87 respectively. Its P/Cash is valued at 1.92.
Earnings per Share Details of Onconova Therapeutics, Inc.:
The EPS of ONTX is strolling at -0.97, measuring its EPS growth this year at 70 percent. As a result, the company has an EPS growth of -7.7 percent for the approaching year.
